Tapentadol: Clinical Trials

12 trials of Tapentadol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 1 terminated. 12 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 212Completed 11, Terminated 1
Phase 11Completed 1
Phase 31Completed 1

Follow Tapentadol: new trials by email Literature Review of Tapentadol trials Research Report on Tapentadol

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Opioid Induced Gait Variability
Tapentadol 50 mg Oral Tablet, Tramadol Hydrochloride 100 mg Extended Release Oral Tablet, Placebo Oral Tablet - Opioid Induced Motor Disturbances
Phase 1 / Phase 2CompletedFrederiksberg University Hospital242015-05-192017-11-06
A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain
Tapentadol prolonged release, Morphine prolonged release - Pain
Phase 2 / Phase 3CompletedGrünenthal GmbH732015-04-292019-09-12
Use of Tapentadol Oral Solution for Pain After Surgery in Children From Newborn to Less Than 2 Years Old
Tapentadol - Moderate to Severe Acute Postoperative Pain
Phase 2TerminatedGrünenthal GmbH402014-11-052018-01-29
Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain
Tapentadol - Postoperative Pain, Acute Pain
Phase 2CompletedGrünenthal GmbH862012-11-012019-11-04
Efficacy and Safety of GRT6005 in Patients With Chronic Low Back Pain.
Matching Placebo, Low Dose GRT6005, Medium Dose GRT6005 - Low Back Pain
Phase 2CompletedTris Pharma, Inc.10892012-11-012021-07-15
Pharmacokinetics and Safety Study of Tapentadol for Postsurgical Pain in Children and Adolescents
Tapentadol (OS) Oral Solution - Pain, Postoperative, Postoperative Pain
Phase 2CompletedJanssen Research & Development, LLC452011-10-012014-07-14
Intravenous Tapentadol in Post-Bunionectomy Pain
Tapentadol, Matching Placebo - Bunion, Pain
Phase 2CompletedGrünenthal GmbH1772011-09-012019-10-28
A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia
Tapentadol, Placebo - Pain, Diabetic Neuropathies
Phase 2CompletedJanssen Pharmaceutical K.K.912010-06-012014-01-13
An Efficacy and Safety Study for Tapentadol Extended Release (JNS024ER) in Chronic Pain Participants
Tapentadol Hydrochloride, Placebo - Pain, Low Back Pain
Phase 2CompletedJanssen Pharmaceutical K.K.912010-04-012013-05-14
Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants
Tapentadol PR - Pain, Cancer
Phase 2CompletedJanssen Pharmaceutical K.K.782008-11-012013-07-29
A Randomized, Double-Blind, Parallel-Arm, Placebo and Active Controlled Dose-Ranging Study of the Efficacy and Safety of Multiple Doses of Tapentadol IR for Postoperative Pain Following Bunionectomy Surgery
tapentadol HCl - Pain, Postoperative Pain
Phase 2CompletedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.4802005-01-012011-05-18
Efficacy and Safety of Tapentadol Extended Release Tablets in the Treatment of Moderate to Severe Pain in Subjects With Knee Osteoarthritis
tapentadol HCl - Osteoarthitis, Chronic Pain
Phase 2CompletedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.6702004-07-012011-05-18

Conditions studied

Pain (6)  ·  Pain, Postoperative (5)  ·  Acute Pain (3)  ·  Chronic Pain (3)  ·  Agnosia (2)  ·  Low Back Pain (2)  ·  Back Pain (1)  ·  Bunion (1)  ·  Diabetic Neuropathies (1)  ·  Neoplasms (1)  ·  Neuralgia (1)  ·  Neuralgia, Postherpetic (1)  ·  Osteoarthritis (1)  ·  Osteoarthritis, Knee (1)

Sponsors

Grünenthal GmbH (4)  ·  Janssen Pharmaceutical K.K. (3)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2)  ·  Frederiksberg University Hospital (1)  ·  Janssen Research & Development, LLC (1)  ·  Tris Pharma, Inc. (1)

Countries

United States (4)  ·  Japan (3)  ·  Spain (3)  ·  United Kingdom (3)  ·  Belgium (2)  ·  Denmark (2)  ·  France (2)  ·  Germany (2)  ·  Hungary (2)  ·  Poland (2)  ·  Austria (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Chile (1)  ·  Finland (1)

Top investigators

Henning Bliddal, DMSc (1)

Results publications

PMID 25985806, PMID 30649458, PMID 31213888

NIH funding

2014 (1)